Abstract
ObjectivesTo compare the efficacy and safety of SB4 (an etanercept biosimilar) with reference product etanercept (ETN) in patients with moderate to severe rheumatoid arthritis (RA) despite methotrexate (MTX) therapy.MethodsThis is...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have